相关实验视频

Updated: Jun 30, 2025

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

KRAS途径中的循环RNA:癌症进展中的新兴参与者

Md Sadique Hussain¹, Ehssan Moglad², Muhammad Afzal³

¹School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan 302017, India.

Pathology, research and practice

|March 19, 2024

概括

循环RNAs (circRNAs) 调节癌症中的KRAS途径,影响基因表达,免疫逃避和药物耐受性. 进一步的研究可能会揭示KRAS驱动的癌症的新诊断和治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

循环RNAs (circRNAs) 是癌症的关键调节者,特别是在KRAS途径内.
KRAS途径是瘤发生过程中的关键信号级联,也是癌症治疗的重点.
循环RNA在基因表达和癌症进展中表现出多种不同的调节作用.

研究的目的:

审查和巩固KRAS途径内circRNAs的当前知识.
突出KRAS驱动癌症中circRNAs的多方面的功能.
讨论癌症治疗的circRNA研究中的挑战和未来方向.

主要方法:

文献综述巩固了关于circRNAs和KRAS通路的现有研究.
鉴定特定的circRNAs (如Circ_GLG1,circitGA7) 以及它们在结直肠癌 (CRC) 中的作用.
讨论circRNA参与免疫逃避,亡和药物耐受性的讨论.

主要成果:

像Circ_GLG1和circITGA7这样的circRNA被确定为CRC中KRAS表达和信号的调节者.
在KRAS驱动的癌症中,circRNAs有助于免疫逃避,亡和耐药性.
挑战包括KRAS突变瘤的异质性和组合疗法的需要.

结论:

了解KRAS通路中的circRNA对于推进癌症诊断和治疗至关重要.
像深度学习这样的新兴技术可以帮助识别与疾病相关的circRNA和治疗点.
持续的研究对于揭开circRNAs和KRAS通路之间的复杂相互作用对于新的癌症策略至关重要.

关键词:

癌症癌症癌症癌症我们的CircRNAS.诊断诊断诊断诊断诊断表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.克拉斯 (Kras) 是一个国家.治疗疗法治疗疗法

更多相关视频

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Identification of Circular RNAs using RNA Sequencing

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

相关概念视频

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Small GTPases - Ras and Rho

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...